admin
Washington D.C. – February 19, 2026 – In a significant move reverberating through the agricultural, environmental, and public health sectors, President Donald Trump late Wednesday issued an executive order mandating a substantial increase in the domestic supply of glyphosate and elemental phosphorus, citing national security imperatives. The directive, titled "Promoting the National Defense by Ensuring an Adequate Supply of Elemental Phosphorus and Glyphosate-Based Herbicides," instructs the Secretary of Agriculture to spearhead efforts to bolster U.S. production of these critical agricultural inputs.
The order’s core objective is to enhance the nation’s self-sufficiency in glyphosate, the active ingredient in the widely used herbicide Roundup, and elemental phosphorus, a foundational component for both glyphosate and vital fertilizers. This strategic pivot comes at a highly contentious time, with Bayer, the German pharmaceutical and life sciences giant that acquired Monsanto in 2018, facing tens of thousands of lawsuits alleging that Roundup causes non-Hodgkin’s lymphoma.
The Executive Order’s Mandate and Rationale
President Trump’s executive order explicitly directs the Secretary of Agriculture to consult with the Secretary of War to ascertain the comprehensive national requirements for materials, services, and facilities necessary to ensure a sustained and adequate domestic supply of elemental phosphorus and glyphosate-based herbicides. A critical provision within the order grants companies complying with its directives waivers from liability, and further stipulates that any subsequent regulations or rules must not jeopardize the "corporate viability of any domestic producer of elemental phosphorus or glyphosate-based herbicides."
The administration’s justification for this unprecedented intervention rests squarely on the concept of national security. The order states, "As the most widely used crop protection tools in United States agriculture, glyphosate-based herbicides are a cornerstone of this Nation’s agricultural productivity and rural economy, allowing United States farmers and ranchers to maintain high yields and low production costs." This framing underscores a concern over potential vulnerabilities in the agricultural supply chain, particularly regarding reliance on foreign sources for essential inputs. By linking agricultural productivity directly to national defense, the administration positions the domestic availability of these substances as a strategic asset, crucial for food security and economic stability.
Chronology of Key Developments Leading to the Order
The executive order is not an isolated event but rather the culmination of several interconnected developments, highlighting a complex interplay of corporate strategy, environmental policy, and legal battles:
- June 2018: Bayer Acquires Monsanto: The acquisition for approximately $63 billion brought with it Monsanto’s controversial product portfolio, including Roundup, and an escalating wave of product liability lawsuits.
- October 2025: Caldwell Canyon Mine Approval: Months prior to the executive order, the Trump administration’s Bureau of Land Management (BLM) approved Bayer’s proposal to construct a new phosphate mine in Idaho. This approval, covering over 1,800 acres of public and private land, is critical as Bayer currently imports the majority of its phosphate, with its existing Idaho mine nearing depletion. The new mine is intended to secure a domestic source of elemental phosphorus, a key raw material for glyphosate. Environmental groups heavily criticized the approval, citing concerns about habitat destruction and water pollution in the region.
- December 2025: Administration Sides with Bayer: The Trump administration officially filed an amicus brief in support of Bayer in a case slated to be heard by the Supreme Court in April 2026. This brief argues that federal law should preempt state-level failure-to-warn claims against glyphosate, essentially seeking to block future lawsuits.
- February 2026: Proposed $7.25 Billion Settlement: Just days before the executive order, Bayer proposed a massive $7.25 billion settlement to resolve thousands of existing lawsuits where individuals claim Roundup exposure led to non-Hodgkin’s lymphoma. This proposed settlement, if approved, would address a significant portion of the company’s legal liabilities but does not resolve the underlying debate about glyphosate’s safety or future litigation.
- February 2026: Farm Bill Immunity Clause: Concurrently, House Republicans included a controversial immunity clause for pesticide manufacturers in a draft "skinny farm bill" presented last week. This legislative effort aims to provide broad protection against product liability lawsuits for companies producing pesticides, aligning with Bayer’s long-standing lobbying efforts to change state and federal laws to prevent future litigation.
Glyphosate: A Cornerstone of Modern Agriculture, A Source of Controversy
Glyphosate, first introduced by Monsanto in the 1970s, rapidly became the world’s most widely used herbicide. Its broad-spectrum efficacy and relatively low cost revolutionized agricultural practices, particularly with the advent of "Roundup Ready" genetically modified crops designed to withstand glyphosate application. This combination facilitated widespread adoption of no-till farming, which can reduce soil erosion and conserve moisture. Global glyphosate usage soared, reaching over 1.8 billion pounds annually worldwide by the mid-2010s. In the United States, an estimated 280 million pounds of glyphosate are applied annually across agricultural and non-agricultural settings.
However, glyphosate’s ubiquity has been matched by escalating controversy. In 2015, the International Agency for Research on Cancer (IARC), a specialized cancer agency of the World Health Organization, classified glyphosate as "probably carcinogenic to humans" (Group 2A). This classification ignited a firestorm of debate, prompting thousands of individuals to file lawsuits against Monsanto (and later Bayer), alleging that exposure to Roundup caused their non-Hodgkin’s lymphoma. While regulatory bodies in several countries, including the U.S. Environmental Protection Agency (EPA), have maintained that glyphosate is not likely to be carcinogenic to humans when used according to label instructions, the IARC classification and subsequent legal victories for plaintiffs have fueled public concern and scrutiny.
Elemental Phosphorus: A Finite Resource with Geopolitical Stakes
Elemental phosphorus is a non-renewable resource essential for life, primarily used in the production of phosphate fertilizers, which are indispensable for global food production. It is also a key ingredient in glyphosate manufacturing. The vast majority of the world’s accessible phosphate rock reserves are concentrated in a few countries, with Morocco holding the largest known deposits, followed by China and Algeria. The United States, while possessing some reserves, has seen its domestic mining capacity decline, leading to increased reliance on imports.
The strategic importance of phosphorus extends beyond agriculture. It is a component in various industrial applications, including detergents, food additives, and certain alloys. Concerns about "peak phosphorus" – the hypothetical point in time when the maximum global production rate of phosphorus is reached – have underscored the need for sustainable management and secure supply chains. For the U.S., ensuring a robust domestic supply of elemental phosphorus reduces vulnerability to geopolitical shifts, trade disputes, or supply disruptions from foreign sources. The executive order’s emphasis on increasing domestic phosphate mining, as exemplified by the Caldwell Canyon approval, directly addresses these strategic concerns.
Diverse Reactions: Support, Dismay, and Skepticism
The executive order elicited a swift and polarized reaction across various stakeholder groups.
Agricultural Industry Support:
House Agriculture Chair G.T. Thompson (R-Pennsylvania) released a statement applauding the order as a "vital step forward" in ensuring farmers retain access to glyphosate. Agricultural industry groups, such as the American Farm Bureau Federation and the National Corn Growers Association, are expected to echo this sentiment. These organizations consistently advocate for policies that maintain the availability of conventional crop protection tools, viewing them as crucial for productivity, profitability, and global competitiveness. They often highlight the role of glyphosate in enabling efficient, large-scale farming, reducing labor costs, and facilitating conservation tillage practices.
Environmental and Public Health Outcry:
Conversely, environmental groups and public health advocates expressed profound dismay. Toxicologist Alexandra Muñoz, a prominent figure associated with Robert F. Kennedy Jr.’s "Make America Healthy Again" (MAHA) movement, decried the order on X (formerly Twitter) as "outrageous and unacceptable." Anti-glyphosate advocate Kelly Ryerson, also on X, emphasized that glyphosate remains "the pesticide MAHA cares about most."
Ken Cook, President of the Environmental Working Group (EWG), issued a scathing critique, stating, "If anyone still wondered whether ‘Make America Healthy Again’ was a genuine commitment to protecting public health or a scam concocted by President Trump and RFK Jr. to rally health-conscious voters in 2024, today’s decision answers that question." This statement reflects a broader skepticism among public health advocates regarding the sincerity of the MAHA movement, especially given Robert F. Kennedy Jr.’s subsequent endorsement of the president’s decision, as reported by The New York Times. The perceived inconsistency has led to accusations of political opportunism, suggesting that health concerns might be secondary to broader political alliances or strategic endorsements.
Environmental organizations, including the Sierra Club and Natural Resources Defense Council (NRDC), are likely to condemn the order. Their concerns would center on the environmental impact of increased phosphate mining, including habitat destruction, water quality degradation from runoff, and the potential for increased pesticide use to harm biodiversity and ecosystem health. They would also reiterate calls for a transition to more sustainable agricultural practices that reduce reliance on synthetic chemical inputs.
Bayer’s Position:
While Bayer has not issued an immediate public statement directly on the executive order, the company’s long-standing legal and lobbying efforts clearly align with the order’s intent. The approval of the Caldwell Canyon mine, the administration’s amicus brief to the Supreme Court, and the proposed immunity clause in the Farm Bill all reflect a concerted effort to de-risk its glyphosate business. The executive order essentially provides federal backing and potential financial or regulatory relief for expanding domestic production, which would be highly favorable to Bayer’s strategic objectives.
Legal and Legislative Implications: A Push for Immunity
The executive order arrives amidst a fervent push by Bayer, the Trump administration, and House Republicans to establish legal immunity for glyphosate producers. The proposed $7.25 billion settlement, while substantial, only addresses a portion of the existing lawsuits and does not prevent future litigation. The underlying legal strategy, which the administration supports in the Supreme Court case, centers on the concept of federal preemption. This legal doctrine argues that federal law (in this case, the EPA’s approval of glyphosate labels) should override state common law claims, thereby shielding manufacturers from lawsuits based on failure-to-warn allegations.
The inclusion of an immunity clause in the draft farm bill represents a legislative attempt to achieve a similar outcome, providing statutory protection against product liability claims for pesticide manufacturers. Should these efforts succeed, either through judicial ruling or legislative action, it would significantly alter the landscape of product liability law for agricultural chemicals, potentially limiting consumers’ ability to seek redress for alleged harm. Critics argue that such immunity would undermine public health protections and corporate accountability, creating a dangerous precedent for other industries.
Economic and Agricultural Impact
From an economic perspective, the executive order could have several significant impacts. For Bayer, it offers a degree of certainty and federal support for a product line that has been under immense legal and financial pressure. Increased domestic production of elemental phosphorus would reduce supply chain risks and potentially stabilize input costs for glyphosate manufacturing.
For U.S. farmers, the order aims to ensure a reliable and affordable supply of glyphosate, which remains a critical tool for many conventional agricultural operations. Proponents argue that this stability is essential for maintaining competitive food prices and ensuring American agricultural output. However, the order could also be seen as entrenching a reliance on chemical-intensive farming at a time when consumer demand for organic and sustainably produced foods is growing, potentially creating a divide within the agricultural sector.
The directive to the Secretary of Agriculture to consult with the Secretary of War suggests that the federal government might explore various mechanisms to incentivize domestic production, including grants, subsidies, or direct procurement. This could stimulate investment in new mining operations and chemical manufacturing facilities, creating jobs in specific regions but also potentially drawing criticism for favoring certain industries over others.
Broader Implications and Future Outlook
The executive order marks a significant moment in the ongoing debate over the balance between agricultural productivity, environmental protection, and public health. By framing the issue as a national security concern, the Trump administration has elevated the status of glyphosate and phosphorus production to a strategic imperative, potentially overriding other considerations.
The order’s long-term implications will depend on several factors:
- Regulatory Implementation: How the Secretary of Agriculture, in consultation with the Secretary of War, translates the order into concrete policies, regulations, and incentives will be crucial.
- Legal Challenges: Environmental and public health groups may challenge the order on various grounds, including environmental impact assessments for new mining projects or the liability waiver provisions.
- Judicial Rulings: The Supreme Court’s decision in the upcoming glyphosate case will have profound implications for future product liability lawsuits and the efficacy of the order’s liability waiver.
- Legislative Action: The fate of the immunity clause in the Farm Bill will also shape the legal landscape for pesticide manufacturers.
- Public Opinion and Market Shifts: Despite governmental support, evolving public perception and consumer preferences for healthier, more sustainable food systems could continue to pressure the market away from glyphosate-dependent agriculture.
Ultimately, the executive order on glyphosate and elemental phosphorus represents a bold and controversial assertion of federal authority aimed at fortifying a specific segment of the agricultural supply chain. Its lasting impact will be measured not only by its success in boosting domestic production but also by its influence on the broader discourse surrounding food systems, public health, and environmental stewardship in the United States.
